Globe Newswire
Transaction in Own Shares
October 05, 2026
• • • • • • • • • • • • • • • •
Shell plc (the 'Company') announces that on 05 October 2026 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
Date of PurchaseNumber of Shares purchasedHighest price paidLowest price paidVolume weighted average price paid per shareVenueCurrency05/10/2026825,000£ 36.3750£ 35.7950£... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Jupiter Fund Management Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and... (continue reading...)FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:Jupiter Fund Management Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and... (continue reading...)More Globe Newswire
View Older Stories-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Neinor seals new €110mn JV, brings cash forward and improves guidance to 2028
-
VirTra Wins Five-Year CBP Contract With Up to $14 Million in Potential Value
-
Transactions in connection with share buy-back program
-
Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
-
IESE launches Global CFO program
-
Notice of Additional Buyback Offer for Admiral Markets AS Bonds
-
Disclosure of total number of voting rights and number of shares in the capital at September 30, 2026
-
WUBEN Prime Day 2026 Offers Exclusive Rewards
-
Resolution Therapeutics to present interim Phase I/II EMERALD study data on RTX001 as a late-breaker at AASLD 2026
-
Optimum Strategic Communications to Host 18th Annual Healthcare Investor Conference
-
Caseware Verity-Powered Risk Suggestion Agent Launches to Help Auditors Identify Engagement-Specific Risks
-
PropLaunch Joins Forces with Axcera and RUBIK to Help Founders Launch Prop Firms
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Xometry Names Marc Teulières as General Manager for Europe to Accelerate Regional Adoption
-
HI-VIEW RESOURCES COMPLETES 2026 EXPLORATION FIELD PROGRAM IN THE TOODOGGONE MINING DISTRICT, BRITISH COLUMBIA
-
Canada’s project boom could generate $443B in revenues for SMEs: BDC study
-
RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
-
Rewind Therapeutics Secures Additional Financing to Advance Oral GPR17 Remyelination Program
-
Jeppesen ForeFlight Airflow™ Agents Debut for Commercial Aviation, Centered on Operating Intelligence and Adoption Flexibility
-
Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
-
RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01
-
One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by Virtual KOL Event
-
One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by Virtual KOL Event
-
Gabriel Holding A/S upwardly adjusts its expectations for the financial year 2025/26 for the continuing operations.
-
Verdora Excellence Alliance Expands Intelligent Capital and Risk Management Framework
-
New Beauty Platform GlowEra Launches to Help Women Look Their Best Without Expensive Procedures
-
LUBIS EDA Launches FormalOS: Infrastructure for Systematic, Scalable Formal Verification
-
KVB Accelerates Middle East Footprint with Strategic MENA Regional Expansion
-
LG U+ selects the Digital Vending Machine® from Bango to expand its subscription bundling
-
Equinor ASA: Share buy-back – third tranche for 2026
-
Statement regarding possible offer
-
Production update and FTSE 250 Index inclusion
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
Progress on share buyback programme
-
Orion Pharma announces agreement with Qilu Pharma Europe for pembrolizumab biosimilar for European market
-
Bulk Peptides: Kylo Peptides Launches Bulk Research Program for High-Volume Laboratories
-
Sender registration lifts Lleida.net's SMS traffic towards Spain operators by 40%
-
Kylo Peptides Review Brings Transparency to the Research Peptide Market
-
Bpce: BPCE and Banco Sabadell announce BPCE’s friendly acquisition of a participation in Banco Sabadell and their intention to explore strategic cooperation
-
Press Release : Availability of the aide-mémoire for Q3 2026 results
-
Nox Peptides Announces Expanded Research Focus on BPC-157 as Canadian Peptide Research Supply Demand Grows
-
Trifork strengthens focus on the public sector with new Vice President
-
Peptides Canada Operated by Growth Guys Announces Launch of Domestic Research Peptide Supply Platform
-
ALSTOM S.A: Aide-memoire ahead of H1 2026/27 publication
-
Start of Day Message
-
TextMagic group’s sales results for Q3 2026
-
Trifork Group strengthens Executive Management with Group COO role
-
AB Tewox has fully redeemed its EUR 35 million bond issue (ISIN LT0000409567)


